The Effect of Vitamin D Supplementation on Skeletal Muscle in the mdx Mouse Model of Duchenne Muscular Dystrophy

被引:4
|
作者
Debruin, Danielle A. [1 ,2 ]
Andreacchio, Nicola [1 ]
Hanson, Erik D. [1 ,3 ]
Timpani, Cara A. [1 ,2 ]
Rybalka, Emma [1 ,2 ]
Hayes, Alan [1 ,2 ,4 ]
机构
[1] Victoria Univ, Inst Sport & Hlth, Melbourne, Vic 3011, Australia
[2] Australian Inst Musculoskeletal Sci AIMSS, Melbourne, Vic 3021, Australia
[3] Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA
[4] Univ Melbourne, Melbourne Med Sch, Melbourne, Vic 3010, Australia
来源
SPORTS | 2019年 / 7卷 / 05期
关键词
1,25(OH)2D: 1,25-dihydroxyvitamin D; 25(OH)D: 25-hydroxyvitamin D3; DMD: Duchenne Muscular Dystrophy; mdx: Duchenne Muscular Dystrophy Mouse Model; Skeletal muscle; 25-HYDROXYVITAMIN D; POWER OUTPUT; D DEFICIENCY; CALCIUM; FIBERS; STRENGTH; PATHOGENESIS; METABOLISM; MECHANISM; THERAPY;
D O I
10.3390/sports7050096
中图分类号
G8 [体育];
学科分类号
04 ; 0403 ;
摘要
Vitamin D (VitD) has shown to be beneficial in reversing muscle weakness and atrophy associated with VitD deficiency. Duchenne muscular dystrophy is characterized by worsening muscle weakness and muscle atrophy, with VitD deficiency commonly observed. This study aimed to investigate the effect of VitD supplementation on dystrophic skeletal muscle. Eight-week old female control (C57BL/10; n = 29) and dystrophic (C57BL/mdx; n = 23) mice were randomly supplemented with one of three VitD enriched diets (1000, 8000 & 20,000 IU/kg chow). Following a four-week feeding period, the extensor digitorum longus (EDL) and soleus muscles contractile and fatigue properties were tested ex vivo, followed by histological analysis. As expected, mdx muscles displayed higher mass yet lower specific forces and a rightward shift in their force frequency relationship consistent with dystrophic pathology. There was a trend for mdx muscle mass to be larger following the 20,000 IU/kg diet, but this did not result in improved force production. Fiber area in the EDL was larger in mdx compared to controls, and there were higher amounts of damage in both muscles, with VitD supplementation having no effect. Four weeks of VitD supplementation did not appear to have any impact upon dystrophic skeletal muscle pathology at this age.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Gut-muscle axis: establishing the connection between microbial signaling and skeletal muscle function in a mouse model (mdx) of Duchenne muscular dystrophy
    Marullo, Anthony
    O'Halloran, Ken
    PHYSIOLOGY, 2024, 39
  • [32] Natural disease history of the D2-mdx mouse model for Duchenne muscular dystrophy
    van Putten, Maaike
    Putker, Kayleigh
    Overzier, Maurice
    Adamzek, W. A.
    Pasteuning-Vuhman, Svetlana
    Plomp, Jaap J.
    Aartsma-Rus, Annemieke
    FASEB JOURNAL, 2019, 33 (07): : 8110 - 8124
  • [33] Dietary NaCl supplementation prevents muscle necrosis in a mouse model of Duchenne muscular dystrophy
    Yoshida, M
    Yonetani, A
    Shirasaki, T
    Wada, K
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2006, 290 (02) : R449 - R455
  • [34] Mitochondrial bioenergetic dysfunction in the D2.mdx model of Duchenne muscular dystrophy is associated with microtubule disorganization in skeletal muscle
    Ramos, Sofhia V.
    Hughes, Meghan C.
    Delfinis, Luca J.
    Bellissimo, Catherine A.
    Perry, Christopher G. R.
    PLOS ONE, 2020, 15 (10):
  • [35] Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy
    Milad, Nadia
    White, Zoe
    Tehrani, Arash Y.
    Sellers, Stephanie
    Rossi, Fabio M. V.
    Bernatchez, Pascal
    SKELETAL MUSCLE, 2017, 7
  • [36] Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy
    Nadia Milad
    Zoe White
    Arash Y. Tehrani
    Stephanie Sellers
    Fabio M.V. Rossi
    Pascal Bernatchez
    Skeletal Muscle, 7
  • [37] Amitriptyline is efficacious in ameliorating muscle inflammation and depressive symptoms in the mdx mouse model of Duchenne muscular dystrophy
    Manning, Jennifer
    Kulbida, Rebecca
    Rai, Prerana
    Jensen, Lindsay
    Bouma, Judith
    Singh, Sanjay P.
    O'Malley, Dervla
    Yilmazer-Hanke, Deniz
    EXPERIMENTAL PHYSIOLOGY, 2014, 99 (10) : 1370 - 1386
  • [38] Moderate-term dimethyl fumarate treatment reduces fibrosis of skeletal and cardiac muscle in in the mdx mouse model of Duchenne muscular dystrophy
    Timpani, C.
    Kourakis, S.
    Bagaric, R.
    Qi, B.
    Ali, B.
    Spiesberger, G.
    Boyer, R.
    Kandhari, N.
    Yan, X.
    Stupka, N.
    van Putten, M.
    Aartsma-Rus, A.
    Deveson-Lucas, D.
    Fischer, D.
    Rybalka, E.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [39] Intraosseous transplant of dystrophin expressing chimeric (DEC) cells improves skeletal muscle function in mdx mouse model of Duchenne muscular dystrophy
    Malik, Mohammad
    Siemionow, Maria
    Cwykiel, Joanna
    Heydemann, Ahlke
    Garcia-Martinez, Jesus
    Siemionow, Krzysztof
    Szilagyi, Erzsebet
    POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2022, 18 (04): : 399 - 406
  • [40] Neural control of respiratory musculature in the <it>mdx</it> mouse model of Duchenne muscular dystrophy
    Burns, David
    O'Driscoll, Eabha
    Lucking, Eric
    O'Connor, Karen
    Clarke, Gerard
    Walter, Glenn
    Edge, Deirdre
    Fuller, David
    O'Halloran, Ken
    FASEB JOURNAL, 2020, 34